CP c.250A>G ;(p.I84V)

Variant ID: 3-148930382-T-C

NM_000096.3(CP):c.250A>G;(p.I84V)

This variant was identified in 11 publications

View GRCh38 version.




Publications:


MetalProGNet: a structure-based deep graph model for metalloprotein-ligand interaction predictions.

Chemical Science
Jiang, Dejun D; Ye, Zhaofeng Z; Hsieh, Chang-Yu CY; Yang, Ziyi Z; Zhang, Xujun X; Kang, Yu Y; Du, Hongyan H; Wu, Zhenxing Z; Wang, Jike J; Zeng, Yundian Y; Zhang, Haotian H; Wang, Xiaorui X; Wang, Mingyang M; Yao, Xiaojun X; Zhang, Shengyu S; Wu, Jian J; Hou, Tingjun T
Publication Date: 2023-02-22

Variant appearance in text: CP: I84V
PubMed Link: 36845922
Variant Present in the following documents:
  • SC-014-D2SC06576B-s003.xlsx, sheet 1
View BVdb publication page



MDM-TASK-web: MD-TASK and MODE-TASK web server for analyzing protein dynamics.

Computational And Structural Biotechnology Journal
Sheik Amamuddy, Olivier O; Glenister, Michael M; Tshabalala, Thulani T; Tastan Bishop, Özlem Ö
Publication Date: 2021

Variant appearance in text: CP: I84V
PubMed Link: 34589183
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



An iterative computational design approach to increase the thermal endurance of a mesophilic enzyme.

Biotechnology For Biofuels
Sammond, Deanne W DW; Kastelowitz, Noah N; Donohoe, Bryon S BS; Alahuhta, Markus M; Lunin, Vladimir V VV; Chung, Daehwan D; Sarai, Nicholas S NS; Yin, Hang H; Mittal, Ashutosh A; Himmel, Michael E ME; Guss, Adam M AM; Bomble, Yannick J YJ
Publication Date: 2018

Variant appearance in text: CP: I84V
PubMed Link: 30002729
Variant Present in the following documents:
  • 13068_2018_Article_1178.pdf
View BVdb publication page



Functional roles of Mg2+ binding sites in ion-dependent gating of a Mg2+ channel, MgtE, revealed by solution NMR.

Elife
Maruyama, Tatsuro T; Imai, Shunsuke S; Kusakizako, Tsukasa T; Hattori, Motoyuki M; Ishitani, Ryuichiro R; Nureki, Osamu O; Ito, Koichi K; Maturana, Andrès D AD; Shimada, Ichio I; Osawa, Masanori M
Publication Date: 2018-04-03

Variant appearance in text: CP: I84V
PubMed Link: 29611805
Variant Present in the following documents:
  • Main text
View BVdb publication page



Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals.

Journal Of The International Aids Society
Arruda, Monica B MB; Boullosa, Lídia T LT; Cardoso, Cynthia C CC; da Costa, Carolina M CM; Alves, Carlos Rb CR; de Lima, Shirlene Ts ST; Kaminski, Helena T HT; Aleixo, Agdemir W AW; Esposito, Ana Op AO; Cavalcanti, Ana Ms AM; Riedel, Maristela M; Couto-Fernandez, José C JC; Ferreira, Selma B SB; de Oliveira, Ivi Cm IC; Portal, Loreci E LE; Wolf, Hilda Hc HH; Fernandes, Sandra B SB; de M C Pardini, Maria I MI; Feiteiro, Manoel Vc MV; Tolentino, Fernanda M FM; Diaz, Ricardo S RS; Lopes, Giselle Isl GI; Francisco, Roberta Bl RB; Véras, Nazle Mc NM; Pires, Ana F AF; Franchini, Miriam M; Mesquita, Fábio F; Tanuri, Amilcar A; ,
Publication Date: 2018-03

Variant appearance in text: CP: I84V
PubMed Link: 29504269
Variant Present in the following documents:
  • JIA2-21-e25032.pdf
View BVdb publication page



Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study.

Medicine
Llibre, Josep M JM; Cozzi-Lepri, Alessandro A; Pedersen, Court C; Ristola, Matti M; Losso, Marcelo M; Mocroft, Amanda A; Mitsura, Viktar V; Falconer, Karolin K; Maltez, Fernando F; Beniowski, Marek M; Vullo, Vincenzo V; Hassoun, Gamal G; Kuzovatova, Elena E; Szlavik, János J; Kuznetsova, Anastasiia A; Stellbrink, Hans-Jürgen HJ; Duvivier, Claudine C; Edwards, Simon S; Laut, Kamilla K; Paredes, Roger R; ,
Publication Date: 2016-10

Variant appearance in text: CP: I84V
PubMed Link: 27749561
Variant Present in the following documents:
  • Main text
View BVdb publication page



Short-Term Dynamic and Local Epidemiological Trends in the South American HIV-1B Epidemic.

Plos One
Junqueira, Dennis Maletich DM; de Medeiros, Rubia Marília RM; Gräf, Tiago T; Almeida, Sabrina Esteves de Matos SE
Publication Date: 2016

Variant appearance in text: CP: I84V
PubMed Link: 27258369
Variant Present in the following documents:
  • pone.0156712.pdf
View BVdb publication page



Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients.

Aids Research And Therapy
Mata-Marín, José Antonio JA; Huerta-García, Gloria G; Domínguez-Hermosillo, Juan Carlos JC; Chavez-García, Marcelino M; Banda-Lara, Marco Isaac MI; Nuñez-Rodríguez, Nohemí N; Cruz-Herrera, Javier Enrique JE; Sandoval-Ramírez, Jorge Luis JL; Martínez-Abarca, Ivan I; Villagómez-Ruíz, Alfredo Francisco AF; Manjarrez-Tellez, Bulmaro B; Gaytán-Martínez, Jesús J
Publication Date: 2015

Variant appearance in text: CP: I84V
PubMed Link: 26413132
Variant Present in the following documents:
  • Main text
  • 12981_2015_Article_72.pdf
View BVdb publication page



Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

Plos One
Sutherland, Katherine A KA; Parry, Chris M CM; McCormick, Adele A; Kapaata, Anne A; Lyagoba, Fred F; Kaleebu, Pontiano P; Gilks, Charles F CF; Goodall, Ruth R; Spyer, Moira M; Kityo, Cissy C; Pillay, Deenan D; Gupta, Ravindra K RK; ,
Publication Date: 2015

Variant appearance in text: CP: I84V
PubMed Link: 26382239
Variant Present in the following documents:
  • Main text
View BVdb publication page



Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina.

Journal Of The International Aids Society
Rodriguez-Rodrigues, Nahuel N; Duran, Adriana A; Bouzas, María Belen MB; Zapiola, Ines I; Vila, Marcelo M; Indyk, Debbie D; Bissio, Emiliano E; Salomon, Horacio H; Dilernia, Dario A DA
Publication Date: 2013-10-03

Variant appearance in text: CP: I84V
PubMed Link: 24093951
Variant Present in the following documents:
  • JIAS-16-18519.pdf
View BVdb publication page



Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens.

Plos One
Smith, Robert A RA; Raugi, Dana N DN; Pan, Charlotte C; Coyne, Matthew M; Hernandez, Alexandra A; Church, Brad B; Parker, Kara K; Mullins, James I JI; Sow, Papa Salif PS; Gottlieb, Geoffrey S GS; ,
Publication Date: 2012

Variant appearance in text: CP: I84V
PubMed Link: 23028968
Variant Present in the following documents:
  • Main text
View BVdb publication page